Ensysce Net Debt vs Other Current Liab Analysis
ENSC Stock | USD 0.62 0.01 1.59% |
Ensysce Biosciences financial indicator trend analysis is much more than just examining Ensysce Biosciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ensysce Biosciences is a good investment. Please check the relationship between Ensysce Biosciences Net Debt and its Other Current Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.
Net Debt vs Other Current Liab
Net Debt vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ensysce Biosciences Net Debt account and Other Current Liab. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Ensysce Biosciences' Net Debt and Other Current Liab is 0.42. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Ensysce Biosciences, assuming nothing else is changed. The correlation between historical values of Ensysce Biosciences' Net Debt and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Ensysce Biosciences are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Net Debt i.e., Ensysce Biosciences' Net Debt and Other Current Liab go up and down completely randomly.
Correlation Coefficient | 0.42 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Other Current Liab
Most indicators from Ensysce Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ensysce Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.At present, Ensysce Biosciences' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 3.22, whereas Issuance Of Capital Stock is forecasted to decline to about 8.5 M.
2023 | 2024 (projected) | Interest Income | 98.6K | 93.6K | Tax Provision | 281.2K | 373.2K |
Ensysce Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Ensysce Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ensysce Biosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 196.5M | 351.8K | 16.4M | 5.9M | 2.7M | 2.6M | |
Total Current Liabilities | 2.8M | 7.0M | 16.5M | 9.5M | 3.3M | 6.2M | |
Total Stockholder Equity | 186.2M | (6.4M) | (8.2M) | (4.0M) | (651.3K) | (618.7K) | |
Retained Earnings | 2.5M | (56.0M) | (85.8M) | (110.9M) | (121.6M) | (115.5M) | |
Cash | 1.1M | 194.2K | 12.3M | 3.1M | 1.1M | 1.1M | |
Other Assets | 5K | 3.8K | 754.8K | 585.9K | 527.3K | 500.9K | |
Cash And Short Term Investments | 1.1M | 194.2K | 12.3M | 3.1M | 1.1M | 1.1M | |
Common Stock Shares Outstanding | 98.3K | 68.8K | 84.0K | 179.9K | 2.3M | 3.9M | |
Long Term Debt Total | 566.3K | 791.3K | 4.4M | 140.2K | 161.2K | 153.1K | |
Liabilities And Stockholders Equity | 196.5M | 351.8K | 16.4M | 5.9M | 2.7M | 2.6M | |
Capital Surpluse | 2.9M | 2.5M | 78.0M | 107.2M | 123.3M | 129.5M | |
Total Liab | 10.3M | 7.0M | 24.6M | 9.9M | 3.4M | 3.2M | |
Total Current Assets | 1.2M | 347.9K | 15.7M | 5.3M | 2.3M | 2.2M | |
Short Term Debt | 2.6M | 4.3M | 12.7M | 4.3M | 854.7K | 812.0K | |
Common Stock | 181.2M | 1.6K | 2.5K | 642.0 | 315.0 | 299.25 | |
Other Current Liab | 2.8M | 856.0K | 3.4M | 2.3M | 542.3K | 515.1K | |
Net Debt | (494.9K) | 4.1M | 483.4K | 1.3M | (268.9K) | (255.5K) | |
Accounts Payable | 540.8K | 1.7M | 301.1K | 2.9M | 1.9M | 1.4M | |
Non Current Assets Total | 195.3M | 3.9K | 754.8K | 585.9K | 419.2K | 398.3K | |
Non Currrent Assets Other | (351.0) | 3.8K | (24.7B) | 558.7K | 419.2K | 440.2K | |
Non Current Liabilities Total | 7.6M | 6.8M | 8.1M | 450.5K | 26.4K | 25.1K | |
Other Current Assets | 138.6K | 153.7K | 3.4M | 2.2M | 1.2M | 1.3M | |
Other Stockholder Equity | 2.5M | 49.5M | 77.7M | 106.9M | 120.9M | 127.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Ensysce Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.69) | Revenue Per Share 0.985 | Quarterly Revenue Growth (0.64) | Return On Assets (1.56) | Return On Equity (13.20) |
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.